Dilip Shanghvi

Showing of 1 - 20 from 38 results
Dilip Shanghvi - Total results - 38
Sun Pharma, SPARC ink pact for potential treatment for atopic dermatitis, auto-immune disorders
Business

Sun Pharma, SPARC ink pact for potential treatment for atopic dermatitis, auto-immune disorders

Sun Pharmaceutical Industries Ltd and Sun Pharma Advanced Research Company (SPARC) on Thursday said they have entered into a worldwide licensing pact for development and commercialisation of a novel molecule which can be used for the potential treatment of atopic dermatitis, psoriasis and other auto-immune disorders

US Food and Drug Administration flags Sun Pharma's Halol plant, warns product approvals may be put on hold
Business

US Food and Drug Administration flags Sun Pharma's Halol plant, warns product approvals may be put on hold

Sun Pharmaceutical Industries seems to have suffered a setback as the US Food and Drug Administration (FDA) has placed its Halol plant under ‘official action indicated’.

Sun Pharma will form ethics panel to supervise corporate governance-related matters: Dilip Shanghvi
Business

Sun Pharma will form ethics panel to supervise corporate governance-related matters: Dilip Shanghvi

In January this year, Sun Pharma had announced a slew of measures, including replacement of its domestic formulations distributor Aditya Medisales and change of auditors for its arms.

Sun Pharma's MD Dilip Shanghvi says shareholders not disadvantaged in transactions with Aditya Medisales
Business

Sun Pharma's MD Dilip Shanghvi says shareholders not disadvantaged in transactions with Aditya Medisales

Drug major Sun Pharmaceutical Industries has said its shareholders were not disadvantaged in transactions with Aditya Medisales and the company has responded to queries from market regulator Sebi

Sun Pharma shares pledged to raise fund for Suraksha; realty firm uses same method thrice in past two years for money
Business

Sun Pharma shares pledged to raise fund for Suraksha; realty firm uses same method thrice in past two years for money

Shanghvi Finance, which is a major shareholder in Sun Pharma, pledged a portion of its stake in India’s largest drugmaker to facilitate Suraksha Realty for raising Rs 100 crore through commercial paper.

Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker
Business

Sebi examines whistleblower complaint against Sun Pharma: All you need to know about issue plaguing drugmaker

In August 2017, Sun Pharmaceutical, Shanghvi and nine other entities settled an insider trading probe on payment of Rs 18 lakh towards settlement charges

Sun Pharma shares drop 3% as SEBI examines whistleblower complaint against the company
Business

Sun Pharma shares drop 3% as SEBI examines whistleblower complaint against the company

Shares of Sun Pharmaceutical fell over 3 percent on Thursday, a day after markets regulator SEBI said it is examining the whistleblower complaint against the company.

Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi
Business

Sun Pharma open to evaluate some past decisions; has not received any query so far from SEBI: Dilip Shanghvi

Dilip Shanghvi, founder and managing director of Sun Pharma said the company will work towards re-establishing credibility and corporate governance

Sun Pharma shares slump 10% as SEBI plans to reopen insider trading case to probe alleged lapses by some of its promoters
Business

Sun Pharma shares slump 10% as SEBI plans to reopen insider trading case to probe alleged lapses by some of its promoters

Shares of Sun Pharmaceutical tumbled over 10 percent on Monday as markets regulator SEBI may reopen an insider trading case against the firm and probe alleged lapses by some of its promoters

Sensex surges over 200 points on US-China trade truce; Nifty up; metal, realty, FMCG stocks biggest gainers
Business

Sensex surges over 200 points on US-China trade truce; Nifty up; metal, realty, FMCG stocks biggest gainers

The Sensex was trading 181.52 points, or 0.50 percent, higher at 36,375.82 at 0945 hrs.

Forbes billionaires 2018 ranking: With $40 bn, Mukesh Ambani richest Indian; Jeff Bezos tops global rich list
Business

Forbes billionaires 2018 ranking: With $40 bn, Mukesh Ambani richest Indian; Jeff Bezos tops global rich list

Mukesh Ambani's net worth has soared to $40.1 billion, making him the richest Indian for the 11th year in a row, while Amazon founder Jeff Bezos toppled Bill Gates as the world's wealthiest person, says Forbes

Mukesh Ambani tops Forbes' 2017 list of India's 100 richest tycoons, Azim Premji ranks second
Business

Mukesh Ambani tops Forbes' 2017 list of India's 100 richest tycoons, Azim Premji ranks second

According to the Forbes list, the total wealth of India's top 100 billionaires, which stands at a whopping $479 billion, is more than the country's foreign exchange reserves estimated at $402.5 billion in September 2017

Sun Pharma Q3 profit dips 5% to Rs 1,472 crore; co to focus on existing business
Business

Sun Pharma Q3 profit dips 5% to Rs 1,472 crore; co to focus on existing business

The company's total income from operations rose however to Rs 7,912.66 crore for the third quarter of the current fiscal, from Rs 7,122.31 crore in the year-ago period

Mukesh Ambani retains India's top businessman list for 9th year with networth at $22.7 bn: Forbes
Business

Mukesh Ambani retains India's top businessman list for 9th year with networth at $22.7 bn: Forbes

Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion

3 firms drop off payments bank list: What is spooking the aspirants?
Business

3 firms drop off payments bank list: What is spooking the aspirants?

When the RBI commenced the licencing process for payments banks, the idea was to offer one more layer of payments services to the yet-to-be banked in the country.

Large corporates Shanghvi, Telenor, IDFC Bank back out from payments bank
Business

Large corporates Shanghvi, Telenor, IDFC Bank back out from payments bank

They are the second applicant to withdraw from the licence after Cholamandalam group pulled out of payments banks race a couple of months back

Mukesh Ambani, Premji, Shanghvi among world's 50 wealthiest
Business

Mukesh Ambani, Premji, Shanghvi among world's 50 wealthiest

Mukesh Ambani, Azim Premji and Dilip Shanghvi - have made it to a global list of 50 wealthiest people that is topped by Bill Gates.

Dhirubhai Ambani, Mistry, Shanghvi get Padma awards
Business

Dhirubhai Ambani, Mistry, Shanghvi get Padma awards

Business tycoon late Dhirubhai Ambani and construction magnate Pallonji Shapoorji Mistry are among industrialists chosen for this year's highest civilian awards that recognise the country's best talents.

Sun Pharma shares plunge on USFDA warning letter to its Halol plant
Business

Sun Pharma shares plunge on USFDA warning letter to its Halol plant

Fresh warning letter to the company issued on Saturday comes after the facility was first inspected by the US drug regulator in September 2014

Total wealth of India's super rich tops UAE GDP: 5 facts from Hurun list
Business

Total wealth of India's super rich tops UAE GDP: 5 facts from Hurun list

According to the report, the combined wealth of these 296 individuals is a staggering $478 billion, which is 22% of India’s GDP last year.